“…doctors and researchers caution that the public needs to stick to the advice of the FDA and the Centers for Disease Control and Prevention. ‘People have to be very careful about statements that come from Big Pharma. They have a very different goal.’” […]
The week in healthcare reform “This is a fundamental change in the architecture of Medicare. … Medicare is evolving into … a marketplace of private plans with a public plan as a backup option.” Medicare Has Become More of a Private Marketplace […]
“The National Academy of Sciences itself for years has been collecting generous gifts from foundations, universities and corporations, including at least $10 million from major drugmakers since 2015, its treasurer reports show.” National Academies’ Report Took Pharma-Friendly Stance After Millions in […]
“When Medicare was created, its architects assumed expansion, both in terms of population and in terms of benefits later. … They didn’t anticipate the shift in American politics to the right, and they didn’t anticipate that Medicare would be labeled a fiscal problem […]
The week in healthcare reform “The scrutiny insurers faced last year after reporting such high profits — in some cases doubling the amount they made the year before — has largely faded away.” Pandemic Profits: Top US Health Insurers Make Billions […]
“But what if the financial cost of not getting vaccinated were just too high? If patients thought about the price they might need to pay for their own care, maybe they would reconsider remaining unprotected.” Analysis: Don’t Want […]
“When you do all the right things, ask all the right questions and you’re still hit with a large bill because of some weird technicality….” At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040 […]
The week in healthcare reform “Companies were fined over … the cost of prescription drugs and delays in getting appropriate treatment … failure to provide timely notice of whether a claim was accepted or denied, or to acknowledge receipt of a […]
